Antibody-drug conjugate (ADC) technology Educational session

ADCs and new targets in solid tumours (ID 37)

Lecture Time
15:00 - 15:15
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)
Antibody-drug conjugate (ADC) technology Educational session

Tumour-targeted immune-stimulating antibody conjugates (ISACs): A new class of immuno-oncology therapeutics (ID 38)

Lecture Time
15:15 - 15:30
Speakers
  • Shelley Ackerman (Redwood City, CA, United States of America)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Shelley Ackerman (Redwood City, CA, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Live Q&A and discussion (ID 39)

Lecture Time
15:30 - 15:45
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)
  • Noboru Yamamoto (Chuo-ku, Japan)
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
  • Shelley Ackerman (Redwood City, CA, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Clinical development of next generation ADCs (ID 35)

Lecture Time
14:30 - 14:45
Speakers
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Re-positioning the payload (ID 36)

Lecture Time
14:45 - 15:00
Speakers
  • Noboru Yamamoto (Chuo-ku, Japan)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Noboru Yamamoto (Chuo-ku, Japan)
Cellular therapy for solid tumours Educational session

Can CAR-T have efficacy in solid tumors? (ID 10)

Lecture Time
14:45 - 15:00
Speakers
  • Sonia Guedan (Barcelona, Spain)
Room
Channel 1
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Sonia Guedan (Barcelona, Spain)
Cellular therapy for solid tumours Educational session

PSMA targeted CAR-T therapy (ID 11)

Lecture Time
15:00 - 15:15
Speakers
  • Bruce Levine (Philadelphia, PA, United States of America)
Room
Channel 1
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Bruce Levine (Philadelphia, PA, United States of America)
Cellular therapy for solid tumours Educational session

Gamma delta T-cell therapeutics for treatment of solid tumors (ID 12)

Lecture Time
15:15 - 15:30
Speakers
  • Lawrence Lamb (Birmingham, AL, United States of America)
Room
Channel 1
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Lawrence Lamb (Birmingham, AL, United States of America)
Cellular therapy for solid tumours Educational session

Live Q&A and discussion (ID 13)

Lecture Time
15:30 - 15:45
Speakers
  • Kapil Dhingra (New York, NY, United States of America)
Room
Channel 1
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Kapil Dhingra (New York, NY, United States of America)
  • Jean-Charles Soria (Villejuif, CE, France)
  • Mark Cobbold (Charlestown, IN, United States of America)
  • Sonia Guedan (Barcelona, Spain)
  • Bruce Levine (Philadelphia, PA, United States of America)
  • Lawrence Lamb (Birmingham, AL, United States of America)
Cellular therapy for solid tumours Educational session

Innovative strategies CAR-T in solid tumors (ID 159)

Lecture Time
14:30 - 14:45
Speakers
  • Mark Cobbold (Charlestown, IN, United States of America)
Room
Channel 1
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Mark Cobbold (Charlestown, IN, United States of America)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes Industry satellite

Introduction (ID 347)

Lecture Time
16:00 - 16:10
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
  • Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes Industry satellite

Antibody engineering: Novel technologies, antibody drug conjugates and mechanisms of action (ID 348)

Lecture Time
16:10 - 16:30
Speakers
  • Matthias Peipp (Kiel, Germany)
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
  • Matthias Peipp (Kiel, Germany)